L-Selenomethionine promotes cell cycle progression and is known to elevate the expression of the antioxidant enzymes thioredoxin reductase, glutathione reductase, and glutathione peroxidase. It has also been shown to selectively induce apoptosis in LNCaP prostate cancer cells without affecting non-cancerous cells.